BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27439913)

  • 1. NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications.
    Angelino G; De Pasquale MD; De Sio L; Serra A; Massimi L; De Vito R; Marrazzo A; Lancella L; Carai A; Antonelli M; Giangaspero F; Gessi M; Menchini L; Scarciolla L; Longo D; Mastronuzzi A
    BMC Cancer; 2016 Jul; 16():512. PubMed ID: 27439913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRAS
    Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
    Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
    Kolin DL; Geddie WR; Ko HM
    Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.
    Küsters-Vandevelde HV; van Engen-van Grunsven IA; Coupland SE; Lake SL; Rijntjes J; Pfundt R; Küsters B; Wesseling P; Blokx WA; Groenen PJ
    Pathol Oncol Res; 2015 Apr; 21(2):439-47. PubMed ID: 25315378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of primary leptomeningeal melanomatosis mimicking subacute meningitis.
    Aslan S; Gocmen R; Acar NP; Khasiyev F; Gumeler E; Soylemezoglu F; Tuncer A; Arsava EM; Topçuoglu MA; Unal Cevik I
    Neuroradiol J; 2018 Feb; 31(1):42-46. PubMed ID: 28627959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
    Ekedahl H; Cirenajwis H; Harbst K; Carneiro A; Nielsen K; Olsson H; Lundgren L; Ingvar C; Jönsson G
    Br J Dermatol; 2013 Nov; 169(5):1049-55. PubMed ID: 23855428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature.
    Martin-Blondel G; Rousseau A; Boch AL; Cacoub P; Sène D
    Clin Neuropathol; 2009; 28(5):387-94. PubMed ID: 19788056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary leptomeningeal melanomatosis: early leptomeningeal enhancement on MRI.
    Celli P; Acqui M; Trillò G; Ramundo EO; D'Andrea G; Roperto R; Ferrante L
    J Neurosurg Sci; 2001 Dec; 45(4):235-40. PubMed ID: 11912478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.
    Küsters-Vandevelde HV; Küsters B; van Engen-van Grunsven AC; Groenen PJ; Wesseling P; Blokx WA
    Brain Pathol; 2015 Mar; 25(2):209-26. PubMed ID: 25534128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic challenges of primary diffuse leptomeningeal melanomatosis in early adolescence: A case report.
    Yamauhci S; Fukuyama T; Inaba Y; Nakajima H; Hattori Y; Miyairi Y; Ogiso Y
    Brain Dev; 2022 Jun; 44(6):421-425. PubMed ID: 35260265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
    Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
    J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.
    Uguen A; Talagas M; Costa S; Samaison L; Paule L; Alavi Z; De Braekeleer M; Le Marechal C; Marcorelles P
    Diagn Pathol; 2015 Jul; 10():121. PubMed ID: 26204954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
    Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
    Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Amelanotic Leptomeningeal Melanomatosis in a Child: A Rare but Severe Disease.
    Szathmari A; Perbet R; Hermier M; Di Rocco F; Frappaz D; Mottolese C
    World Neurosurg; 2016 Aug; 92():581.e15-581.e20. PubMed ID: 27319310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system malignant melanoma with leptomeningeal melanomatosis: a case report and review of the literature.
    Fujimori K; Sakai K; Higashiyama F; Oya F; Maejima T; Miyake T
    Neurosurg Rev; 2018 Jan; 41(1):333-339. PubMed ID: 28986666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary diffuse leptomeningeal gliomatosis mimicking tuberculous meningitis.
    Kosker M; Sener D; Kilic O; Hasiloglu ZI; Islak C; Kafadar A; Batur S; Oz B; Cokugras H; Akcakaya N; Camcioglu Y
    J Child Neurol; 2014 Dec; 29(12):NP171-5. PubMed ID: 24284232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomas.
    Fortin Ensign S; Bollin K; Millis SZ; Hinds BR; Kosty M; Uchiyama C
    Pigment Cell Melanoma Res; 2020 May; 33(3):458-465. PubMed ID: 31663661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An NRAS mutation in primary malignant melanoma of the lung: a case report.
    Hibiya T; Tanaka M; Matsumura M; Aoki A; Ikegami T; Okudela K; Kawano N; Ohashi K
    Diagn Pathol; 2020 Feb; 15(1):11. PubMed ID: 32028967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma.
    Pracht M; Mogha A; Lespagnol A; Fautrel A; Mouchet N; Le Gall F; Paumier V; Lefeuvre-Plesse C; Rioux-Leclerc N; Mosser J; Oger E; Adamski H; Galibert MD; Lesimple T
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1530-8. PubMed ID: 25623140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.